BIOS — Biosenic SA Income Statement
0.000.00%
Last trade - 00:00- €0.85m
- €25.97m
Annual income statement for Biosenic SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 1 | 1 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 7.95 | 16 | 13 | 2.32 | 23.1 |
| Operating Profit | -7.95 | -15 | -12 | -2.32 | -23.1 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -7.52 | -15.8 | -12.8 | -3.05 | -29 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -7.52 | -15.8 | -12.9 | -3.05 | -29 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -10.5 | -11.9 | -12.9 | -2.04 | -28.8 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -10.5 | -11.9 | -12.9 | -2.04 | -28.8 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.802 | -1.35 | -0.767 | -0.017 | -0.134 |
| Dividends per Share |